Citation Impact
Citing Papers
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Gastric cancer
2016 Standout
Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone Levels
2000
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Clinical trials in primary hepatocellular carcinoma: current status and future directions
1988
Syndemics and the biosocial conception of health
2017 Standout
Adenovirus infection induces amplification of persistent viral DNA sequences (simian virus 40, hepatitis B virus, bovine papillomavirus) in human and rodent cells
1990 StandoutNobel
Hepatocellular carcinoma
2018 Standout
Metabolic Disturbances and Wasting in the Acquired Immunodeficiency Syndrome
1992
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
1995
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia
1997
Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS
2011
Metabolism and reactions of quinoid anticancer agents
1987
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin
1991
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Rapid mucosal CD4+ T-cell depletion and enteropathy in simian immunodeficiency virus–infected rhesus macaques
1999
Single-Dose Toxicity Study of Hepatic Intra-arterial Infusion of Doxorubicin Coupled to a Novel Magnetically Targeted Drug Carrier
2001
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
2004
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Chemotherapy for advanced gastric cancer
2010
Growth Hormone Improves Lean Body Mass, Physical Performance, and Quality of Life in Subjects With HIV-Associated Weight Loss or Wasting on Highly Active Antiretroviral Therapy
2004
Treatment Guidelines for HIV-Associated Wasting
2000
Chemotherapy for advanced gastric cancer
2005
Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis
2002
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss
2008
Cancer-associated cachexia
2018 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Toxicity profile of dexrazoxane (zinecardR, icrf-187, adr-529, nsc-169780), a modulator of doxorubicin cardiotoxicity
1991
Clinical Pharmacokinetics of Doxorubicin
1988
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Inhibition of N‐methyl‐N′'‐nitro‐n‐nitrosoguanidine‐induced methotrexate and adriamycin resistance in CHO cells by adeno‐associated virus type 2
1990 StandoutNobel
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Prognostic Factors in Patients With Hepatocellular Carcinoma Receiving Systemic Chemotherapy
1992
5-Fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma
1994
Chronic hepatitis B
2007 Standout
A Randomized Controlled Trial Evaluating Nutrition Counseling with or without Oral Supplementation in Malnourished HIV-Infected Patients
1998
Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment
2000
Recombinant α2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial
1989
Doxorubicin clearance in the obese.
1988
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Gastric cancer
2020 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Dissociation of carcinogen-induced SV40 DNA-Amplification and amplification of AAV DNA in a Chinese hamster cell line
1988 StandoutNobel
Wasting as independent risk factor for mortality in chronic heart failure
1997
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Nonresectional therapies for hepatocellular carcinoma
1997
Hepatocellular carcinoma
2022 Standout
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
1998 Standout
Bioelectrical impedance analysis?part I: review of principles and methods
2004 Standout
Patterns of metastasis and natural courses of breast carcinoma
1985
Selective dna‐amplification induced by carcinogens (initiators): Evidence for a role of proteases and DNA polymerase alpha
1985 StandoutNobel
Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracycline
1989
Serum Dihydrotestosterone and Testosterone Concentrations in Human Immunodeficiency Virus‐Infected Men With and Without Weight Loss
1999
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
2005
Gene amplification, drug resistance, and cancer.
1984
Effect of Dronabinol on Nutritional Status in HIV Infection
1993
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
1985 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein
1989
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
2016
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Role of Quinones in Toxicology
2000 Standout
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus
1986 StandoutNobel
Hepatocellular carcinoma
2000
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Cannabinoids for Medical Use
2015 Standout
Effects of Testosterone Replacement with a Nongenital, Transdermal System, Androderm, in Human Immunodeficiency Virus-Infected Men with Low Testosterone Levels1
1998
Gastrointestinal T Lymphocytes Retain High Potential for Cytokine Responses but Have Severe CD4+T-Cell Depletion at All Stages of Simian Immunodeficiency Virus Infection Compared to Peripheral Lymphocytes
1998
Serum hormones in men with human immunodeficiency virus-associated wasting.
1996
The clinical course of bone metastases from breast cancer
1987 Standout
Systemic chemotherapy for hepatocellular carcinoma
1992
AETIOPATHOGENESIS OF HEPATOCELLULAR CARCINOMA
1996
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of Chlebowski Rt being referenced
Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.
1981
Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
1980
Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS.
1989
Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.
1985
Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell line.
1982
Concomitant razoxane and doxorubicin treatment on a weekly schedule.
1984
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results.
1984
Metabolism of methotrexate in man after high and conventional doses.
1980
Frequency and treatment of primary hepatocellular carcinoma in Los Angeles.
1981